Press ReleasesClever Leaves Strengthens German Presence Through Expanded Cantourage Partnership

Clever Leaves Strengthens German Presence Through Expanded Cantourage Partnership

-

CLEVER Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today the continued expansion of the Company’s partnership with European medical cannabis leader Cantourage GmbH (“Cantourage”) to include supply of Clever Leaves’ second pharmaceutical-grade cannabis product, cultivated in the Company’s Portugal Facilities, to the German medicinal cannabis market.

Clever Leaves will supply Cantourage with high-THC dried flower product from the Company’s Wappa strain, cultivated in Clever Leaves’ facility in Portugal, where the company operates approximately 25,000 mof actively producing GACP-certified greenhouse. Cantourage will utilize Clever Leaves’ product to produce IQANNA 10 which will have one of the highest THC levels available in German pharmacies.

Clever Leaves and Cantourage’s expanded partnership further increases the range of international, high-quality medical cannabis products available to the EU market under Clever Leaves’ brand IQANNA and further strengthen the Company as a multinational operator.

Andres Fajardo, CEO of Clever Leaves, emphasized “This partnership expansion provides us the opportunity to continue fulfilling Clever Leaves’ commitment to patients around the world seeking high-quality, safe and efficacious medicinal cannabis solutions. We are excited to launch additional high quality products in Germany under the IQANNA brand.” Mr. Fajardo continued, “Expanding the distribution of our products with partners such as Cantourage is an important objective for the Company’s operations in the European market and enables Clever Leaves to strengthen our supply chain in fast-growing markets such as Germany”.

Cantourage processes and distributes medical cannabis products sourced from around the world and makes them available to patients in Germany and Europe. IQANNA No 10 is the second Clever Leaves product made available to patients in Germany, with further products under the Clever Leaves IQANNA brand to be introduced in Germany in the coming weeks.

Latest news

British People Open To Using Medical Cannabis – Yet Majority Unaware They Can Access It On Prescription 

A NEW national survey of 4,000 people has highlighted the need to improve awareness of cannabis as a medicine.  Key...

As US Hemp Cultivation Levels Plummet The Established European Industry Continues To Flourish 

DESPITE a huge decline in US hemp industry’s footprint the European industry will continue to grow, say the continent’s...

Chrystal Capital Acts As Exclusive Advisor To Change Agronomy On £9.6m Fundraise

CHRYSTAL Capital Partners LLP, is an entrepreneurial corporate finance and investment house with an established global network of Single...

European Cannabis Stocks Review: ‘End’ Of US Cannabis Bear Market Rallies European Stocks 

FOLLOWING last week’s rally there has seen something of a lull with little movement for European cannabis stocks. Last week’s...

Business of Cannabis Conference Returns to New York City on November 3rd

In this second summit, the most influential business leaders, investors and politicians gather to discuss social equity, policy and...

Curaleaf Takes Majority Stake And Forms Strategic Partnership With Germany’s Four 20 Pharma In €20m Deal

CURALEAF Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading U.S. provider of consumer products in cannabis, announced that Curaleaf International...

Must read

As US Hemp Cultivation Levels Plummet The Established European Industry Continues To Flourish 

DESPITE a huge decline in US hemp industry’s footprint...

European Cannabis Stocks Review: ‘End’ Of US Cannabis Bear Market Rallies European Stocks 

FOLLOWING last week’s rally there has seen something of...

You might also likeRELATED
Recommended to you